1044 Journal of Natural Products, 2009, Vol. 72, No. 6
Ren et al.
eluting with MeOH to yield four subfractions (SF1-SF4). SF1 (300 mg)
mainly contained peptides as determined by 1H NMR spectroscopy, and
it was subsequently separated on semipreparative HPLC (YMC, 10 µm,
10 × 250 mm) with a mobile phase of MeOH-H2O (70:30) to obtain 1
(79 mg, tR 73.9 min), 6 (15 mg, tR 85.2 min), a mixture of 2 and 3 (43
mg), and a mixture of 4 and 5 (32 mg). The mixture of 2 and 3 was then
separated by semipreparative HPLC (YMC, 10 µm, 10 × 250 mm) using
CH3CN-H2O (4:6) as the mobile phase to obtain 2 (7.0 mg, tR 31.5 min)
and 3 (8.0 mg, tR 46.5 min), while the mixture of 4 and 5 was separated
by the same protocol as for compounds 2 and 3 using CH3CN-H2O (38:
62) as the mobile phase to yield 4 (12 mg, tR 71.5 min) and 5 (15 mg, tR
87.5 min).
H5-5), -1.60 (1H, m, H-4a), -3.44 (1H, m, H-4b), -3.22 (1H, m,
R-H), -4.70 (1H, m, NH).
Acknowledgment. This work was supported by grants from NSFC
(No. 30672607), the National Hi-Tech Projects (2006AA09Z446,
2006DFA31100, 2007AA09Z448, 2006AA09Z405, 2007AA09Z435),
China Uni-PhD Base Project (20060001149), and International Coop-
eration Projects of BMBF-MOST.
Supporting Information Available: 1D and 2D NMR (COSY,
HMQC, HMBC, NOESY) and ESIMS/MS spectra of compounds 1-6
1
and the H NMR spectra of Ru(D -Por*)CO complexes of reference
4
Aspereline A (1): colorless needles (MeOH); mp 296-298 °C;
standards and the amino acids derived from the peptaibols. This material
[R]20 -42 (c 0.1, MeOH); 1H and 13C NMR data, see Table 1;
D
(-)ESIMS/MS m/z 935 [M - H]-, 893, 808, 723, 624, 539, 426;
(+)ESIMS/MD m/z 937 [M + H]+, 835, 751, 680, 595, 510, 397, 312;
HRESIMS m/z 937.6088 [M + H]+(calcd for C45H81N10O11, 937.6081).
References and Notes
Aspereline B (2): colorless needles (MeOH); mp 273-275 °C; [R]20
D
(1) Bru¨ckner, H.; Becker, D.; Gams, W.; Degenkolb, T. Chem. BiodiVersity
2009, 6, 38–56.
1
-5.0 (c 0.1, MeOH); H and 13C NMR data, see Table 2; (-)ESIMS
m/z 921 [M - H]-, 879, 808, 723, 624, 539, 426; (+)ESIMS m/z 945
[M + Na]+, 815, 731, 660, 575, 490, 377, 292; HRESIMS m/z 945.5744
[M + Na]+ (calcd for C44H78N10O11Na, 945.5743).
(2) Degenkolb, T.; Gams, W.; Bru¨ckner, H. Chem. BiodiVersity 2008, 5,
693–706.
(3) Degenkolb, T.; Bru¨ckner, H. Chem. BiodiVersity 2008, 5, 1817–1843.
(4) Toniolo, H.; Bru¨ckner, H. Peptaibiotics-Fungal Peptides Containing
R-Dialkyl R-Amino Acids, Verlag Helvetica Chimica Acta, Zu¨rich, Wiley-
VCH: Weinheim, 2009.
Aspereline C (3): colorless needles (MeOH); mp 284-285 °C;
[R]20 -22 (c 0.1, MeOH); 1H and 13C NMR data, see Table 2;
D
(-)ESIMS/MS m/z 921 [M - H]-, 879, 794, 709, 610, 525, 412, 327;
(+)ESIMS/MS m/z 945 [M + Na]+, 815, 731, 660, 589, 504, 391,
306; HRESIMS m/z 945.5746 [M + Na]+ (calcd. for C44H78N10O11Na,
945.5743).
(5) Degenkolb, T.; Kirschbaum, J.; Bru¨ckner, H. Chem. BiodiVersity 2007,
4, 1052–1067.
(6) Ishiyama, D.; Satou, T.; Senda, H.; Fujimaki, T.; Honda, R.; Kanazawa,
S. J. Antibiot. 2000, 53, 728–732.
(7) Berg, A.; Schlegel, B.; Ihn, W.; Demuth, U.; Gra¨fe, U. J. Antibiot. 1999,
52, 666–669.
(8) Berg, A.; Ritzau, M.; Ihn, W.; Schlegel, B.; Fleck, W. F.; Heinze, S.;
Gra¨fe, U. J. Antibiot. 1996, 49, 817–820.
(9) Wei, X.; Yang, F.; Straney, D. C. Can. J. Microbiol. 2005, 51, 423–
429.
(10) Reiber, K.; Neuhof, T.; Ozegowski, J. H.; von Do¨hren, H.; Schwecke, T.
J. Pept. Sci. 2003, 9, 701–713.
(11) Duclohier, H. Chem. BiodiVersity 2007, 4, 1023–1026.
(12) Powers, J. S.; Hancock, R. E. Peptides 2003, 24, 1681–1691.
(13) Jenssen, H.; Hamill, P.; Hancock, R. E. Clin. Microbiol. ReV. 2006, 19,
491–511.
(14) Oh, S. U.; Yun, B. S.; Lee, S. J.; Kim, J. H.; Yoo, I. D. J. Antibiot.
2002, 55, 557–564.
(15) Poirier, L.; Quiniou, F.; Ruiz, N.; Montagua, M.; Amiard, J. C.; Pouchus,
Aspereline D (4): colorless needles (MeOH); mp 301-303 °C;
[R]20 -10.5 (c 0.1, MeOH); 1H and 13C NMR data, see Table 2;
D
(-)ESIMS/MS m/z 921 [M - H]-, 879, 794, 709, 610, 525, 426;
(+)ESIMS/MS m/z 945 [M + Na]+, 815, 731, 660, 575, 490, 391,
306, 211; HRESIMS m/z 945.5740 [M
+
Na]+ (calcd for
C44H78N10O11Na, 945.5743).
Aspereline E (5): colorless needles (MeOH); mp 295-297 °C; [R]20
D
1
-12 (c 0.1, MeOH); H and 13C NMR data, see Table 2; (-)ESIMS/
MS m/z 951, 922, 880, 794, 709, 610, 525, 412; (+)ESIMS/MS m/z
976 [M + Na]+, 847, 761, 674, 589, 504, 391, 306; HRESIMS m/z
953.6031 [M + H]+(calcd for C45H81N10O12, 953.6035).
Aspereline F (6): colorless needles (MeOH); mp 281-283 °C; [R]20
D
1
-12 (c 0.1, MeOH); H and 13C NMR data, see Table 2; (-)ESIMS/
MS m/z 949, 907, 822, 723, 624, 539, 426; (+)ESIMS/MS m/z 973
[M + Na]+, 844, 759, 688, 603, 518, 405, 321; HRESIMS m/z 973.6047
[M + Na]+ (calcd for C46H82N10O11Na, 973.6042).
Y. F. Aqua. Toxicol. 2007, 83, 254–262.
(16) Peltola, J.; Ritieni, A.; Mikkola, R.; Grigoriev, P. A.; Po´csfalvi, G.;
Andersson, M. A.; Salkinoja-Salonen, M. S. Appl. EnViron. Microbiol.
2004, 70, 4996–5004.
(17) Bessler, W. G.; Ottenbreit, B.; Irmscher, G.; Jung, G. Biochem. Biophys.
Res. Commun. 1979, 87, 99–105.
(18) Peltola, J.; Ritieni, A.; Mikkola, R.; Grigoriev, P. A.; Po´csfalvi, G.;
Andersson, M. A.; Salkinoja-Salonen, M. S. Appl. EnViron. Microbiol.
2004, 70, 4996–5004.
(19) Wada, S.; Iida, A.; Asami, K.; Tachikawa, E.; Fujita, T. Biochim. Biophys.
Acta 1997, 1325, 209–214.
(20) Katayama, T.; Miyagawa, K.; Kodama, T.; Oikawa, S. Biol. Pharm. Bull.
2001, 24, 1420–1422.
(21) Fuji, K.; Fujita, E.; Takaishi, K.; Fujita, T.; Arita, I.; Komatsu, M.;
Hiratsuka, N. Experientia 1978, 34, 137–140.
(22) Ramot, O.; Viterbo, A.; Friesem, D.; Oppenheim, A.; Chet, I. Curr. Genet.
2004, 45, 205–213.
(23) Watanabe, S.; Kato, H.; Kumakura, K.; Ishibashi, E.; Nagayama, K. J.
Pestic. Sci. 2006, 31, 375–379.
(24) Chutrakul, C.; Alcocer, M.; Bailey, K.; Peberdy, K. J. F. Chem.
BiodiVersity 2008, 5, 1694–1705.
(25) Krause, C.; Kirschbaum, J.; Bru¨ckner, H. Amino Acids 2006, 30, 435–
443.
(26) Przybylski, M.; Dietrich, I.; Manz, I.; Bru¨ckner, H. Biomed. Mass
Spectrom. 1984, 11, 569–582.
(27) Bru¨ckner, H. J. Chromatogr. 1999, 862, 179–189.
(28) Lieckfeldt, E.; Samuels, G. J.; Nirenberg, H. I.; Petrini, O. Appl. EnViron.
Microbiol. 1999, 65, 2418–2428.
(29) Claeson, P.; Go¨ransson, U.; Johansson, S.; Luijendijk, T.; Bohlin, L. J.
Nat. Prod. 1998, 61, 77–81.
(30) Ferrand, Y.; Maux, P. L.; Simonneaux, G. Org. Lett. 2004, 6, 3211–
3214.
Ru((+)-D -Por*)CO preparation. The chiral reagent Ru((+)-D -
4
4
Por*)CO was synthesized as reported.29,30
Configuration Determination. Compound 1 (0.2 mg) was dissolved
in 6 N HCl (2 mL) and heated at 105 °C for 24 h in a sealed ampule. The
resulting solution was cooled to rt and concentrated in vacuo to remove
H2O and HCl. Then, 500 µL of SOCl2-CH3OH (v/v ) 1:10) was added
and heated at 75 °C in a H2O bath for 1 h. The dried sample was mixed
with 40 µL of saturated Na2CO3 to basify the aqueous solution. Then a
0.6 mL solution of 2.0 mg of Ru((+)-D -Por*)CO in CDCl3 was added to
4
extract the amino acids. The CDCl3 layer was quickly passed through a 2
× 5 mm silica gel column and then collected in a NMR tube. A 1H NMR
spectrum was recorded at 600 MHz. The standards L/D Ala, L/D Ile, L/D
Val, L/D Ser, and S/R prolinols were purchased from Sigma, and the same
protocol was used as for 1 to record the 1H NMR spectrum of the individual
complexed amino acids. The complexed amino acid residues from 2-6
were treated similarly to 1.
L-Ala-Ru((+)-D -Por*)CO: 1H NMR δ (CDCl3) -2.00 (3H, d, Me),
4
-3.00 (1H, m, R-H), -4.46 (1H, m, NHa), -5.66 (1H, m, NHb).
1
L-Ile-Ru((+)-D -Por*)CO: H NMR δ (CDCl3) -0.21 (3H, t, J )
4
7.0 Hz, H-4), -0.75 (1H, m, H-3a), -1.10 (1H, m, H-3b), -0.90 (1H,
m, H-2), -1.50 (3H, d, J ) 6.5 Hz, H-5), -2.92 (1H, m, R-H), -4.30
(1H, m, NHa), -5.60 (1H, m, NHb).
L-Val-Ru((+)-D -Por*)CO: 1H NMR δ (CDCl3) -0.90 (1H, m,
4
H-2), -1.10 (3H, d, J ) 6.5 Hz, H-3), -1.36 (3H, d, J ) 6.5 Hz,
H-4), -3.07 (1H, m, R-H), -4.30 (1H, m, NHa), -5.61 (1H, m, NHb).
1
L-Ser- Ru((+)-D -Por*)CO: H NMR δ (CDCl3) -0.87 (1H, m,
4
H-2b), -0.81 (1H, m, H-2b), -2.63 (1H, m, R-H), -4.02 (1H, m, NHa),
(31) Zhang, R.; Yu, W.; Wong, K.; Che, C. J. Org. Chem. 2001, 66,
8145–8153.
-4.18 (1H, m, NHb).
1
S-Prolinol-Ru((+)-D -Por*)CO. H NMR δ (CDCl3) -0.77 (2H,
m, H2-2), -1.42 to -1.52 (2H, m, H2-3), -1.52 to -1.55 (2H, m,
4
NP900190W